Special

• FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
  

  Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.

• The forming, development and monitoring of the pharmaceutical market in USA in September 2011
  

  In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth.

• Sildenafil citrate and pulmonary arterial hypertension
  

  Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: -  Progressive increase in pulmonary vascular resistance; -  Reduction in pulmonary bloodflow; -  High pulmonary artery pressure; -  Contractility of the heart right ventricle; -  Right ventricular failure.

• Fruit and vegetables do not reduce overall cancer risk, review concludes
  

  Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people.

• Common painkillers could be linked to male reproductive disorder
  

  The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study.

News

• UCL spinout takes nano-enabled pain therapy to international markets - MTBeurope
  

  UCL spinout takes nano-enabled pain therapy to international marketsMTBeuropeThe UK Nanotechnology Knowledge Transfer Network (NanoKTN) has announced that member company Nanomerics, a spin-out from UCL School of Pharmacy, is taking its patented nano-enabled therapeutic technology to international markets.

• Skepticism grows around Medco/Express Scripts deal - Reuters
  

  WGN RadioSkepticism grows around Medco/Express Scripts dealReutersBy Diane Bartz | WASHINGTON (Reuters) - Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health Solutions are accumulating as US antitrust regulators weigh whether they have enough evidence to stop the .

• Applied DNA Sciences installs first pharmacy security system - Securing Pharma
  

  Applied DNA Sciences installs first pharmacy security systemSecuring PharmaApplied DNA Sciences has installed its smartDNA anti-intruder mist system at a pharmacy in Long Island, USA, in response to a spate of pharmacy robberies there in recent months.

• Memo offers new account of ATF agent's NY shooting - USA TODAY
  

  USA TODAYMemo offers new account of ATF agent's NY shootingUSA TODAYGARDEN CITY, NJ (AP) – A document accidentally posted on a prosecutor's website cites a pharmacist's version of the friendly fire shooting death of a federal agent during a New Year's Eve robbery and differs from an account offered by an attorney for .

• FDA approves first Cushing's syndrome drug, Corcept's Korlym - The Pharma Letter
  

  FDA approves first Cushing's syndrome drug, Corcept's KorlymThe Pharma LetterShares of USA-based Corcept Therapeutics (Nasdaq: CORT) leapt 62% to $4.